<?xml version='1.0' encoding='utf-8'?>
<Document xmlns="urn:iso:std:iso:20022:tech:xsd:pacs.002.001.10"><FIToFIPmtStsRpt><GrpHdr><MsgId>PACS002-ACSC-a75e57bd</MsgId><CreDtTm>2025-09-26T15:00:00+00:00Z</CreDtTm></GrpHdr><OrgnlGrpInfAndSts><OrgnlMsgId>PAIN-2025-09-26-Atlantic_Pharma_Inc-79aeff77</OrgnlMsgId><OrgnlMsgNmId>pain.001.001.09</OrgnlMsgNmId><GrpSts>PART</GrpSts></OrgnlGrpInfAndSts><OrgnlPmtInfAndSts><OrgnlPmtInfId>PMTINF-2025-09-26-334c61</OrgnlPmtInfId><TxInfAndSts><StsId>STS-123013b9</StsId><OrgnlInstrId>INST-20250926-01018</OrgnlInstrId><OrgnlEndToEndId>E2E-20250926-01018</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-26T15:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="USD">168340.17</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-21afa5fd</StsId><OrgnlInstrId>INST-20250926-01078</OrgnlInstrId><OrgnlEndToEndId>E2E-20250926-01078</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-26T15:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="CAD">12458.22</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-5bff80df</StsId><OrgnlInstrId>INST-20250926-01110</OrgnlInstrId><OrgnlEndToEndId>E2E-20250926-01110</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-26T15:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="GBP">32891.68</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-4c1a7d89</StsId><OrgnlInstrId>INST-20250926-01143</OrgnlInstrId><OrgnlEndToEndId>E2E-20250926-01143</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-09-26T15:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="AUD">6605.66</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts></OrgnlPmtInfAndSts></FIToFIPmtStsRpt></Document>